Navigation Links
ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication
Date:10/22/2007

MORRISTOWN, N.J., Oct. 22 /PRNewswire/ -- Bayer Consumer Care announces the availability of the newly-named ALEVE-D(R) Sinus and Cold (formerly ALEVE Cold and Sinus), combining a long-lasting nasal decongestant with the pain-relieving power of ALEVE (naproxen sodium) for all-day relief from multiple sinus and pain symptoms.

The combination of ingredients in ALEVE-D address consumer concerns as identified in a recent survey of adults who suffer from sinus symptoms. More than half of those polled (56 percent) say they are not completely satisfied with their current sinus medication, reporting that their medication does not last long enough (65 percent) and that they need more than one product to completely relieve their symptoms (62 percent). The symptoms most commonly experienced by those surveyed are stuffy nose or nasal congestion (89 percent), sinus congestion (78 percent) and headache (73 percent).

The active ingredients in ALEVE-D, pseudoephedrine (PSE) and naproxen sodium combine to provide 12 hours of relief from symptoms including sinus pressure, headache, and nasal and sinus congestion.

"Consumers rely on the ALEVE family of products for long-lasting relief," said Jay Kolpon, Vice President, Marketing and New Business Development, Bayer Consumer Care. "With ALEVE-D, we are offering consumers the power of ALEVE combined with the proven effectiveness of pseudoephedrine in one pill that provides 12 hours of relief from sinus and pain symptoms."

Each ALEVE-D caplet contains naproxen sodium (220mg) and PSE HCL (120mg). Adults and children 12 years and older may take one caplet every eight to 12 hours while symptoms last, and should not exceed two capsules in a 24-hour period. ALEVE-D is available exclusively behind the pharmacy counter without a prescription.

For more information, visit http://www.AleveD.com.

About ALEVE and ALEVE-D

Since its introduction as an OTC
'/>"/>

SOURCE Bayer Consumer Care
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cost-effective antibiotics for sinusitis treatment
2. Humming helps sinusitis
3. Chronic Fatigue, Pain Linked to Sinusitis
4. Asthma Patients With Sinusitis More Difficult To Treat
5. Drug Resistance Questioned in Patients With Chronic Sinusitis
6. Chronic Sinusitis May Be Related To Nasal Mucus
7. Children With Sinusitis Lead A Better Life After Surgery
8. Age Can Changes Symptoms Of Sinusitis
9. Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus
10. Immune Response Linked to “Ghost” Parasites and Severely Congested Sinuss
11. Chronic Sinusitis Resulting From Weakene Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3At Nearly $120 Million, The Hepatitis C Drug Market in Brazil is Among the Largest Emerging Pharmaceutical Markets for the Disease 2Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 2Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 3Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 4ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement 5898 1ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement 5898 2ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement 5898 3ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement 5898 4Martel Instruments Expands Its Custom Printer Solutions Business in North America 3B Liz Peirce Named Director of North American Business Development 60491 1Martel Instruments Expands Its Custom Printer Solutions Business in North America 3B Liz Peirce Named Director of North American Business Development 60491 21 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 11 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 21 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 4